Company: 
About
Mr. Michel Demare has been Non-Executive Director of AstraZeneca PLC since September 1, 2019 and serves as its Chairman since April 27, 2023. He served as the Chief Financial Officer of ABB Ltd. since joining in January 1, 2005 to January 31, 2013. Mr. Demare served as the President/Head of Global Markets at ABB Ltd. from September 2008 to March 1, 2011 and served as its Executive Vice President. Between February 2008 and August 2008, he served as an Interim Chief Executive Officer of ABB. He served as the Chief Executive Officer of ABB Ltd. from February 13, 2008 to September 1, 2008. He served as the Chief Financial Officer for Europe Operations and Vice President at Baxter International Inc. from 2002 to 2005. Mr. Demare has extensive international finance, strategy and M&A experience, gained during his at Dow Chemical. Mr. Demare joined Baxter in 2002. He served with The Dow Chemical Company from 1984 to 2002. At Dow Chemical Company, he held various treasury and Business Chief Financial Officer positions in Europe (including Switzerland) and the US. Mr. Demare joined Dow Chemical as Finance Manager in Brussels in 1984. He served as a Head of global markets of ABB Group. He served as a Group Finance Director\Chief Financial Officer of Global Polyolefins and Elastomers division at The Dow Chemical Company from 1997 to 2002, Director of Financial Risk Management at Dow Chemical, Switzerland from 1995 to 1997, Assistant Treasurer, Dow Europe of Dow Chemical from 1992 to 1995, Senior Finance Manager and Corporate Treasury of Dow Chemical, Midland, USA from 1989 to 1992, Treasurer of Dow France of Dow Chemical, France from 1986 to 1989 and Finance Manager of Dow Benelux of Dow Chemical, Belgium Continental Illinois Bank from 1984 to 1986. He served as a Banking Officer for Multinational Banking Division of Continental Illinois Bank, Belgium from 1980 to 1984. He began his career as an Officer in the multinational banking division of Continental Illinois National Bank of Chicago. He joined UBS Group AG in 2014. He served as the Chairman of the SwissHoldings, the Federation of Industrial and Service Groups in Switzerland from 2013 to 2015. He served as Chairman of the Syngenta Foundation for Sustainable Agriculture since 2013 until December 2017. He served as the Chairman of the Board at Syngenta AG from April 23, 2013 to 2017. He served as Independent Vice Chairman at UBS Group AG since November 2014 until May 3, 2019 and served as Director since April 15, 2009 until May 3, 2019. He served as Independent Vice Chairman at UBS AG since April 2010 and served as its Director since 2009 until May 2, 2019. He has been Non-Executive Director of Vodafone Group Public Limited Company (formerly known as Vodafone AirTouch Public Limited Company) (Vodafone UK) (formerly known as Vodafone Airtouch plc) since February 1, 2018. Mr. Demare served as Vice Chairman and Lead Independent Director at Syngenta AG from June 26, 2017 to December 2017 and as its Non-Executive Director from April 24, 2012 to 2017. He serves as Vice-Chairman of the Supervisory Board of IMD Business School in Lausanne, Switzerland. He is also Chairman of IMD Business School and Chairman of Nomoko AG. He serves as Non-Executive Director of Louis Dreyfus Company Holdings BV. He has been a Member of Supervisory Board at Louis Dreyfus Commodities Holdings BV since April 15, 2014. He serves as a Member of the IMD Foundation Board, Lausanne. He serves as an Advisory Board Member of the Department of Banking and Finance at the University of Zurich and Zukunft Finanzplatz. He holds a Degree in Applied Economics at the Université Catholique de Louvain (UCL), Belgium from 1974 to 1978. Mr. Demare holds MBA from Katholieke Universiteit Leuven (KUL), Belgium from 1979 to 1980.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| AstraZeneca PLC | Board | Member | 01/01/2019 | |
| AstraZeneca PLC | Industry Specific | Chairperson | 01/01/2014 | |
| Louis Dreyfus Company | Audit | Member | 01/01/2014 | |
| Louis Dreyfus Company | Supervisory Board | Chairperson | 01/01/2014 |